ZP4207
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ZP4207, covering 2015-11-11 to 2016-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon [Phase 2]